Latest cloning Stories

The Israeli Office of the Chief Scientist Approved Cell Cure's Development Budget Totaling NIS 11.5 Million (Over $3 Million USD) with non equity based funding of close to 50% JERUSALEM, May 23, 2013 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that its portfolio company,...

Presentation to be Webcast at 2:30 Eastern Time on May 30, 2013 JUPITER, Fla., May 21, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announced that Mark Weinreb, its President and CEO, will be presenting at the Marcum MicroCap Conference. The conference will be held on Thursday, May 30, 2013 at the Grand Hyatt Hotel, located at...

BioInformatics LLC announces the release of their newest market report: The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities. Arlington, VA (PRWEB) May 16, 2013 BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) With barriers to entry low, the number of suppliers in the primary cells market continues to increase. In this study, BioInformatics LLC examines...

Decreasing the amount of oxygen traditionally used when culturing stem cells for use in neurological therapies could drastically affect their survival rate. In fact, it could double it, according to a new study released today in STEM CELLS Translational Medicine. Durham, NC (PRWEB) May 15, 2013 Decreasing the amount of oxygen traditionally used when culturing stem cells for use in neurological therapies could drastically affect their survival rate. In fact, it could double it, according...

LOS ANGELES, May 15, 2013 /PRNewswire/ -- On May 8, 2013, Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical scientist who is believed to be the only person who has patented the technology for direct regeneration of damaged organs has filed a lawsuit against Dr. Shinya Yamanaka, one of the winners of the 2012 Nobel Prize in Physiology or Medicine in the Superior Court of California, County of San Francisco. The lawsuit filed...

LOS ANGELES, May 15, 2013 /PRNewswire/ -- On May 8, 2013, Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical scientist who is believed to be the only person who has patented the technology for direct regeneration of damaged organs has filed a lawsuit against Dr. Shinya Yamanaka, one of the winners of the 2012 Nobel Prize in Physiology or Medicine in the Superior Court of California, County of San Francisco. The lawsuit filed...

WASHINGTON, May 15, 2013 /PRNewswire-USNewswire/ -- Scientists in Oregon announced today that they had created cloned human embryos, and then destroyed the embryos to extract embryonic stem cells. The cloning technique is essentially the same one used to create Dolly the cloned sheep, with some modifications to make cloning work using human eggs and human cells. This is the first claim of growing human embryonic stem cells from cloned human embryos since the fraudulent claims in...

USCCB Pro-Life Chair Responds to Cloning Breakthrough in Oregon Says Creating Embryos To Destroy Them Objectionable to Non-Catholics Too Notes That Morally Acceptable Scientific Advances Already Addressing Same Goals WASHINGTON, May 15, 2013 /PRNewswire-USNewswire/ -- Human cloning for any purpose is inconsistent with the moral responsibility to "treat each member of the human family as a unique gift of God, as a person with his or her own inherent dignity," said the chairman of...

SAN RAMON, Calif., May 15, 2013 /PRNewswire-USNewswire/ -- The Center for Bioethics and Culture strongly decries the practice of deriving human embryonic stem cells through cloning because it exploits women for their eggs, it commodifies human life, and it is unnecessary. In the June 6, 2013, issue of the scientific journal Cell, researchers announce that they have successfully derived human embryonic stem cells through somatic cell nuclear transfer (SCNT) cloning. The authors of the...

Researchers use synthetic silicate to stimulate stem cells into bone cells In new research published online May 13, 2013 in Advanced Materials, researchers from Brigham and Women's Hospital (BWH) are the first to report that synthetic silicate nanoplatelets (also known as layered clay) can induce stem cells to become bone cells without the need of additional bone-inducing factors. Synthetic silicates are made up of simple or complex salts of silicic acids, and have been used extensively...